Sal Bottiglieri, Associate Director Medical Science Liaison – GI, Thoracic Oncology at Eli Lilly and Company, shared on LinkedIn:
“A career first: this October, I’ll be heading to Madrid, Spain, for ESMO 2026, my first global oncology congress.
I’m truly grateful for the opportunity to attend such an impactful meeting, where the global oncology community comes together to share the science shaping the future of cancer care.
From my years in oncology pharmacy to my role in Medical Affairs today, one constant has been the value of learning from others. I’m looking forward to the scientific sessions, the poster sessions, and the conversations that happen in between, all with patients at the center.
Attending ESMO October 23–27? Let me know. I’d be glad to connect and see you there.”
You can also read: OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition
